AEON insider filings

AEON Biopharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen AEON transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Sy Jennifer — Chief Accounting Officer11 leg · 153,846 sh · $19,985——
Bancroft Robert E. — President and CEO, Director11 leg · 152,333 sh · $19,590——
Wilson Alexander Blair — CLO, CSO and Corp Secretary11 leg · 135,706 sh · $17,479——
Daewoong Co., Ltd — 10% owner1——3

Recent insider filings — AEON Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2026-11-204Bancroft Robert E. — President and CEO, DirectorPurchase (P): 152,333 @ $0.13EDGAR
2026-11-204Sy Jennifer — Chief Accounting OfficerPurchase (P): 153,846 @ $0.13EDGAR
2026-11-204Wilson Alexander Blair — CLO, CSO and Corp SecretaryPurchase (P): 135,706 @ $0.13EDGAR
2026-11-104Daewoong Co., Ltd — 10% ownerOption exercise/expiry (X): 11,236,631 @ $0.00 · Other (J): 3,822 @ $0.29 · Option exercise/expiry (X): 11,236,631 (derivative) @ $0EDGAR
2026-08-214LYNCH TIMOTHY P — 10% ownerPurchase (P): 1,150,000 @ $0.21EDGAR
2026-06-224Forth Marc — DirectorGrant/award (A): 222,684 @ $0EDGAR
2026-06-224Carter Eric G — DirectorGrant/award (A): 222,684 @ $0EDGAR
2026-06-224FISCHER JOST — DirectorGrant/award (A): 222,684 @ $0EDGAR
2026-06-224Thunen Shelley B — DirectorGrant/award (A): 222,684 @ $0EDGAR
2026-06-224PALMISANO ROBERT J — DirectorGrant/award (A): 222,684 @ $0EDGAR
2026-04-034Bencich John — CHIEF FINANCIAL OFFICERGrant/award (A): 754,717 @ $0EDGAR
2026-03-114Oh Chad — CHIEF MEDICAL OFFICERGrant/award (A): 862,500 @ $0 · Grant/award (A): 1,316,872 @ $0EDGAR
2026-03-054Wilson Alexander Blair — CLO, CSO, and Corp SecretaryGrant/award (A): 862,500 @ $0 · Grant/award (A): 1,316,872 @ $0EDGAR
2026-03-054Sy Jennifer — PRINCIPAL ACCOUNTING OFFICERGrant/award (A): 575,000 @ $0 · Grant/award (A): 925,925 @ $0EDGAR
2026-02-194Bancroft Robert E. — PRESIDENT & CEO, DirectorGrant/award (A): 3,000,000 @ $0EDGAR
2025-05-234Wilson Alexander Blair — Exec VP, CLO & Corp SecretaryGrant/award (A): 1,316,872 (derivative) @ $0EDGAR
2025-05-234Oh Chad — Chief Medical OfficerGrant/award (A): 1,316,872 (derivative) @ $0EDGAR
2025-05-234Sy Jennifer — Chief Accounting OfficerGrant/award (A): 925,925 (derivative) @ $0EDGAR
2025-05-234Forth Marc — DirectorGrant/award (A): 370,370 (derivative) @ $0EDGAR
2025-05-234Carter Eric G — DirectorGrant/award (A): 308,641 (derivative) @ $0EDGAR
2025-05-234FISCHER JOST — DirectorGrant/award (A): 308,641 (derivative) @ $0EDGAR
2025-05-234FISCHER JOST — DirectorPurchase (P): 60,000 @ $0.49EDGAR
2025-05-234Thunen Shelley B — DirectorGrant/award (A): 308,641 (derivative) @ $0EDGAR
2025-05-234PALMISANO ROBERT J — DirectorGrant/award (A): 308,641 (derivative) @ $0EDGAR
2025-05-214FISCHER JOST — DirectorPurchase (P): 50,000 @ $0.50 · Purchase (P): 60,000 @ $0.51EDGAR
2025-05-164Bancroft Robert E. — President & CEO, DirectorGrant/award (A): 177,103 @ $0EDGAR
2025-05-014Bancroft Robert E. — President & CEO, DirectorGrant/award (A): 59,034 (derivative) @ $0EDGAR
2024-09-104/APALMISANO ROBERT J — DirectorGrant/award (A): 36,021 @ $0EDGAR
2024-09-044Wilson Alexander Blair — EXEC VP, CLO & CORP SECRETARYGrant/award (A): 180,110 @ $0 · Grant/award (A): 480,631 (derivative) @ $0EDGAR
2024-09-044Oh Chad — CHIEF MEDICAL OFFICERGrant/award (A): 192,117 @ $0 · Grant/award (A): 512,673 (derivative) @ $0EDGAR
2024-09-044Sy Jennifer — PRINCIPAL ACCOUNTING OFFICERGrant/award (A): 18,010 @ $0 · Grant/award (A): 48,063 (derivative) @ $0EDGAR
2024-09-044Forth Marc — CHIEF EXECTUIVE OFFICER, DirectorGrant/award (A): 470,692 @ $0 · Grant/award (A): 1,256,062 (derivative) @ $0EDGAR
2024-09-044Carter Eric G — DirectorGrant/award (A): 36,021 @ $0 · Grant/award (A): 96,210 (derivative) @ $0EDGAR
2024-09-044FISCHER JOST — DirectorGrant/award (A): 36,021 @ $0 · Grant/award (A): 96,210 (derivative) @ $0EDGAR
2024-09-044Thunen Shelley B — DirectorGrant/award (A): 36,021 @ $0 · Grant/award (A): 96,210 (derivative) @ $0EDGAR
2024-09-044PALMISANO ROBERT J — DirectorGrant/award (A): 36,021 @ $0 · Grant/award (A): 96,210 (derivative) @ $0EDGAR
2024-04-164/ADaewoong Co., Ltd — 10% ownerOther (J)EDGAR
2024-04-124Daewoong Co., Ltd — 10% ownerOther (J)EDGAR
2024-03-264Daewoong Co., Ltd — 10% ownerOther (J)EDGAR
2024-03-214Oh Chad — CHIEF MEDICAL OFFICERGrant/award (A): 86,720 (derivative) @ $0EDGAR
2024-03-214Wilson Alexander Blair — EXEC VP, CLO & CORP SECRETARYGrant/award (A): 81,300 (derivative) @ $0EDGAR
2024-03-214Forth Marc — CHIEF EXECTUIVE OFFICER, DirectorGrant/award (A): 212,466 (derivative) @ $0EDGAR
2024-03-214Carter Eric G — DirectorGrant/award (A): 16,260 (derivative) @ $0 · Grant/award (A): 8,130 (derivative) @ $0EDGAR
2024-03-214FISCHER JOST — DirectorGrant/award (A): 16,260 (derivative) @ $0EDGAR
2024-03-214Thunen Shelley B — DirectorGrant/award (A): 16,260 (derivative) @ $0EDGAR
2024-03-214PALMISANO ROBERT J — Director, 10% ownerGrant/award (A): 16,260 (derivative) @ $0EDGAR
2023-08-164Carter Eric G — DirectorGrant/award (A): 58,851 (derivative) @ $0EDGAR
2023-08-164FISCHER JOST — DirectorGrant/award (A): 58,851 (derivative) @ $0EDGAR
2023-08-164Thunen Shelley B — DirectorGrant/award (A): 58,851 (derivative) @ $0EDGAR
2023-08-164PALMISANO ROBERT J — Director, 10% ownerGrant/award (A): 58,851 (derivative) @ $0EDGAR

Recent 8-K events — AEON Biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-038-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-308-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-238-K8.01 — Other EventsEDGAR
2026-07-158-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AEON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs